Determination of clopidogrel metabolite (SR26334) in human plasma by LC-MS

Journal of Pharmaceutical and Biomedical Analysis

Volumn 41, Issue 2, 2006, Pages 533-539

  Ksycinska, Hanna ^a   Rudzki, Piotr ^a   Bukowska Kiliszek, Mirosława ^a  

^a INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

Clopidogrel; Human plasma; Liquid chromatography; Liquid liquid extraction on Chem Elut cartridges; Validation

Indexed keywords

2 (2 CHLOROPHENYL) 2 (4,5,6,7 TETRAHYDROTHIENO[3,2 C]PYRIDIN 5 YL)ACETIC ACID; ACETONITRILE; CLOPIDOGREL; DICHLOROMETHANE; DRUG METABOLITE; FORMIC ACID; REPAGLINIDE; WATER;

ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; FLOW RATE; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; MASS SPECTROMETRY; PLATELET AGGREGATION INHIBITORS; REPRODUCIBILITY OF RESULTS; TEMPERATURE; TICLOPIDINE;

EID: 33646001776     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2005.11.035     Document Type: Article

References (12)

1. Lenz T.L., and Wilson A.F. Clin. Pharmacokinet. 42 (2003) 909-920
2. Savi P., Herbert J.M., Pflieger A.M., Dol F., Delebassée D., Combalbert J., Defreyn G., and Maffrand J.P. Biochem. Pharmacol. 44 (1992) 527-532
3. Caplain H., Donat F., Gaud C., and Necciari J. Semin. Thromb. Hemost. 25 (1999) 25-28
4. Pereillo J.-M., Maftouh M., Andrieu A., Uzabiaga M.F., Fedeli O., Savi P., Pascal M., Herbert J.M., Maffrand J.P., and Picard C. Drug Metab. Disp. 30 (2002) 1288-1295
5. Herbert J.M., Frehel D., Vallee E., Kieffer G., Gouy D., Berger Y., Necciati J., Defreyn G., and Maffrand I.P. Cardiovasc. Drug Rev. 11 (1993) 180-198
6. Lagorce P., Perez Y., Ortiz J., Necciari J., and Bressolle F. J. Chromatogr. B 720 (1998) 107-117
7. Grenier J., Ciric S., Curry J., Morelli G., Arseneault A., and Tanguay M. Clin. Pharmacol. Ther. 73 (2003) P47
8. Taubert D., Kastrati A., Harlfinger S., Gorchakova O., Lazar A., von Beckerath N., Schomig A., and Schomig E. Thromb. Haemost. 92 (2004) 311-316
9. Lainesse A., Ozalp Y., Wong H., and Alpan R. Arzneim.-Forsch./Drug Res. 54 (2004) 600-604
10. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Pharm. Res. 17 (2000) 1551-1557
11. Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration. Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001.
12. Note for Guidance on the Investigation of Bioavailability and Bioequivalence, Committee for Proprietary Medicinal Products (CPMP), London, 26 July 2001.